Systemic lupus erythematosus and Atrioventricular block first degree

Summary:

Atrioventricular block first degree is found among people with Systemic lupus erythematosus, especially for people who are female, 60+ old.

The study analyzes which people have Atrioventricular block first degree with Systemic lupus erythematosus. It is created by eHealthMe based on reports of 20 people who have Systemic lupus erythematosus from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,089 drugs and 1,642 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.

What is Atrioventricular block first degree?

Atrioventricular block first degree (heart block first degree) is found to be associated with 647 drugs and 890 conditions by eHealthMe. Check the latest studies of Atrioventricular block first degree.

On Jul, 19, 2026

20 people who have Systemic Lupus Erythematosus and Atrioventricular Block First Degree are studied.

Would you have Atrioventricular block first degree when you have Systemic lupus erythematosus?

Gender of people who have Systemic Lupus Erythematosus and experienced Atrioventricular Block First Degree *:

female: 88.24 %
male: 11.76 %

Age of people who have Systemic Lupus Erythematosus and experienced Atrioventricular Block First Degree *:

Common co-existing conditions for these people *:

Myositis (inflammation of the muscles): 2 people, 10.00%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 5.00%
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased): 1 person, 5.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.00%
Immunodeficiency Disorders: 1 person, 5.00%
High Blood Pressure: 1 person, 5.00%
Fluid Overload (too much fluid in the blood): 1 person, 5.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Cardiomyopathy (weakening of the heart muscle): 11 people, 55.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 45.00%
Cardiac Failure: 7 people, 35.00%
Bundle Branch Block Right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle): 5 people, 25.00%
Septic Shock (shock due to blood infection): 5 people, 25.00%
Chest Pain: 5 people, 25.00%
Right Ventricular Hypertrophy (right ventricular enlargement): 4 people, 20.00%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 4 people, 20.00%
Diastolic Dysfunction: 3 people, 15.00%
Cardiac Failure Congestive: 3 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Atrioventricular block first degree?

- Check whether Atrioventricular block first degree is associated with a drug or a condition

Related publications that referenced our studies

Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .

Related studies:

Treatments, associated drugs and conditions:

Systemic lupus erythematosus (76,947 reports)
Atrioventricular block first degree (6,357 reports)

All the drugs that are associated with Atrioventricular block first degree:

Atrioventricular block first degree (647 drugs)

All the conditions that are associated with Atrioventricular block first degree:

Atrioventricular block first degree (890 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Atrioventricular block first degree and Systemic lupus erythematosus, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.